OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation

BACKGROUND: The once-daily (QD), prolonged-release formulation of tacrolimus has been shown to improve adherence versus twice-daily (BD) tacrolimus. Treatment nonadherence in transplant recipients has been associated with poor graft outcomes. METHODS: This open-label, parallel-group study randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Albano, Laetitia, Banas, Bernhard, Klempnauer, Juergen L., Glyda, Maciej, Viklicky, Ondrej, Kamar, Nassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864174/
https://www.ncbi.nlm.nih.gov/pubmed/23982340
http://dx.doi.org/10.1097/TP.0b013e3182a203bd

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864174/
https://www.ncbi.nlm.nih.gov/pubmed/23982340
http://dx.doi.org/10.1097/TP.0b013e3182a203bd

Ejemplares similares